Category: General

Katie Miller, Key Player in Anti-340B ‘Dark Money’ Campaign, Leaves White House Adviser Role

May 30, 2025 Shannon Young, Associate Editor/Senior Writer Views

Katie Miller, a key figure in a dark money anti-340B campaign, has left her role as a White House adviser.

A Trump administration adviser and key figure in a dark money effort to tie the 340B program to immigration growth, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Cassidy Says 340B ‘Was Never Meant to be Part of an Earnings Call’

May 30, 2025 Shannon Young, Associate Editor/Senior Writer Views

U.S. Sen. Bill Cassidy (R-La.) discussed the 340B program in a recent interview with Punchbowl News.

A key U.S. senator on 340B policy continued to raise concerns this week about the current state of the drug [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

BI Asks Tennessee Contract Pharmacies to Report Claims Data Ahead of New State Law, BMS Updates Contract Pharmacy Restrictions

May 30, 2025 Shannon Young, Associate Editor/Senior Writer Views

Boehringer Ingelheim announced new 340B claims data requirements for Tennessee covered entities.

Tennessee covered entities must now submit claims data for all Boehringer Ingelheim (BI) 340B drugs filled by their in-house pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

HRSA Defends 340B Hospital Drug Purchasing Restrictions Policy, Asks Federal Court to Reject Premier’s Challenge

May 28, 2025 Shannon Young, Associate Editor/Senior Writer Views

HHS attorneys recently urged a Washington D.C. federal court to uphold a 2013 HRSA policy and reject Premier's claim that it unlawfully restricts how certain 340B hospitals can purchase initial drug inventory.

The Trump administration this month urged a Washington D.C. federal court to uphold a 2013 Health Resources and Services Administration [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Vermont House Modifies 340B Contract Pharmacy Access and Hospital Reporting Bill, Hospital Advocates Voice Concerns About Changes

May 28, 2025 Shannon Young, Associate Editor/Senior Writer Views

Vermont House lawmakers voted Friday to approve an amended contract pharmacy access bill, which includes price caps on some hospitals that has raised concerns from some state health systems.

The Vermont House on Friday approved a 340B contract pharmacy access bill with Senate-backed hospital reporting requirements and a new [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Oregon, Illinois State Senators Push for Amendments to 340B Contract Pharmacy Access Bills

May 28, 2025 William Newton, Associate Editor/Senior Writer Views

Oregon state senators have proposed competing amendments to a 340B contract pharmacy access bill that passed the state House.

Oregon state senators are pushing for competing amendments to a 340B contract pharmacy access bill that passed the state House; [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Provider-Drugmaker Lobbying Group Adds Hospital, Drugmaker: Key Thune Staffer Departs for Private Sector

May 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

The 340B Working Table has added Boston Medical Center Health System and Takeda Pharmaceuticals America to its list of members.

A novel lobbying group established by 340B provider organizations and one of the world’s largest drugmakers recently added another major [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Genentech Tightens Contract Pharmacy Restrictions to Require Hospital Claims Data, Targets 340B Drug Redistribution; 340B Lawyer Pushes Back

May 22, 2025 Shannon Young, Associate Editor/Senior Writer Views

Genentech updated its contract pharmacy restrictions to impose new claims data submissions and prevent covered entities from shipping 340B drugs to other locations through “alternate distribution models” or other channels.

A California-based drugmaker this week updated its contract pharmacy restrictions to impose new claims data submissions for hospitals and prevent [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Drug Industry-Backed AIDS Group Targets 340B in New Ad Campaign

May 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

ADAP Advocacy, a drug industry funded group, recently released a minute-long ad that argues 340B unduly benefits providers and could be rife with “fraud, waste and abuse.”

A pharmaceutical industry-funded HIV/AIDS advocacy group is taking aim at the 340B program—questioning if it’s “too big to fail”—in a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Mixed Responses So Far to RFK Jr.’s Comments on 340B Program from 340B Provider Groups

May 15, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B advocates offered tepid responses to HHS Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program on Wednesday.

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s first public remarks on the 340B program—which 340B Report broke [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Staff Email

Site Footer Live